Replies to post #507457 on $Stock*Shop*Charts*News*Option$

[Tuff-Stuff]

UP> Goldman adds Amgen (AMGN) to its coveted Conviction Buy list saying investors have already factored in Q4 and H2 2015 patent expirations for some of the company's "key biologic franchises." Furthermore, AMGN's pipeline and "own biosimilars will allow it to replace the potential revenue that could be lost to competition."

[CohibaMan]

No wonder why all the harbors are polluted, LOL.

That is one heck of a HUGE miss. That is worse than when EZ said "Yep, this Edsel is the CAR OF THE FUTURE!"